ACE and &agr;-Adducin Polymorphism as Markers of Individual Response to Diuretic Therapy

Abstract—Renin-angiotensin system reactivity and the constitutive capacity of the renal tubule to reabsorb sodium play a role in the individual response to diuretic therapy; therefore we evaluated the blood pressure (BP) response to hydrochlorothiazide in 87 never-treated individuals with mild essential hypertension, according to ACE gene I/D and &agr;-adducin Gly460Trp polymorphism. These genotypes where chosen because previous data showed their interaction in determining the BP response to salt probably was the result of their involvement in the activation of the renin-angiotensin system (ACE) and in the constitutive capacity of the kidney to reabsorb sodium (&agr;-adducin) (treatment for 2 months). BP was measured after 3 run-in visits and after the first and second months of treatment by means of a standardized procedure. Data were analyzed by ANOVA, t test, and multivariate ANOVA for repeated measures (covarying for gender, age, and body mass index). Although basal mean BP (MBP) was similar in the different ACE and &agr;-adducin genotypes, patients carrying at least one I allele of ACE and one 460Trp allele of &agr;-adducin had the largest MBP decrease with treatment (12.7±1.9 mm Hg), the effect of the combination of genotypes being additive but not epistatic. These patients had an odds ratio of 15.75 of being a responder to hydrochlorothiazide compared with patients with Gly460Gly+DD, with the least MBP decrease (3.4±1.7 mm Hg). &agr;-Adducin and ACE I/D polymorphism may be useful to predict the interindividual degree of response to hydrochlorothiazide; the analysis of the combination of the 2 genotypes increases the accuracy of the prediction of response to the drug.

[1]  B. Beermann,et al.  Antihypertensive effect of various doses of hydrochlorothiazide and its relation to the plasma level of the drug , 1978, European Journal of Clinical Pharmacology.

[2]  R. Henning,et al.  Enhanced responses of blood pressure, renal function, and aldosterone to angiotensin I in the DD genotype are blunted by low sodium intake. , 2002, Journal of the American Society of Nephrology : JASN.

[3]  N. Glorioso,et al.  &agr;-Adducin 460Trp Allele Is Associated With Erythrocyte Na Transport Rate in North Sardinian Primary Hypertensives , 2002, Hypertension.

[4]  N. Markandu,et al.  Importance of the Renin System for Determining Blood Pressure Fall With Acute Salt Restriction in Hypertensive and Normotensive Whites , 2001, Hypertension.

[5]  H. Brunner.  Experimental and clinical evidence that angiotensin II is an independent risk factor for cardiovascular disease. , 2001, The American journal of cardiology.

[6]  E. Boerwinkle,et al.  C825T Polymorphism of the G Protein &bgr;3-Subunit and Antihypertensive Response to a Thiazide Diuretic , 2001, Hypertension.

[7]  R. Butler.  The DD-ACE genotype and cardiovascular disease. , 2000, Pharmacogenomics.

[8]  N. Schork,et al.  Synergistic effect of alpha-adducin and ACE genes causes blood pressure changes with body sodium and volume expansion. , 2000, Kidney international.

[9]  A. de la Sierra,et al.  Renin-angiotensin system genetic polymorphisms and salt sensitivity in essential hypertension. , 2000, Hypertension.

[10]  Trevor Gerdsen.  Hypertension Renin-Angiotensin System Genetic Polymorphisms and Salt Sensitivity in Essential , 2000 .

[11]  J. Maldonado.  Blood pressure screening, management and control in England: results from the Health Survey for England 1994. , 1999, Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology.

[12]  P. Manunta,et al.  Evidence for an interaction between adducin and Na+-K+-ATPase: relation to genetic hypertension. , 1999, American journal of physiology. Heart and circulatory physiology.

[13]  M D'Amico,et al.  Adducin polymorphism affects renal proximal tubule reabsorption in hypertension. , 1999, Hypertension.

[14]  Bruce Neal,et al.  1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. Guidelines Subcommittee. , 1999, Journal of hypertension.

[15]  N. Poulter,et al.  Blood pressure screening, management and control in England: results from the health survey for England 1994 , 1998, Journal of hypertension.

[16]  N. Graudal,et al.  Effects of sodium restriction on blood pressure, renin, aldosterone, catecholamines, cholesterols, and triglyceride: a meta-analysis. , 1998, JAMA.

[17]  A. Hasegawa,et al.  Renal ACE immunohistochemical localization in NIDDM patients with nephropathy. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[18]  J. Staessen,et al.  The deletion/insertion polymorphism of the angiotensin converting enzyme gene and cardiovascular‐renal risk , 1997, Journal of hypertension.

[19]  Cristina Barlassina,et al.  Polymorphisms of α-adducin and salt sensitivity in patients with essential hypertension , 1997, The Lancet.

[20]  J. Staessen,et al.  The insertion/deletion polymorphism of the angiotensin-converting enzyme gene and car-diovascular-renal risk : a meta-analysis , 1997 .

[21]  L Zagato,et al.  Polymorphisms of alpha-adducin and salt sensitivity in patients with essential hypertension. , 1997, Lancet.

[22]  M. Ishida,et al.  Angiotensin I-converting enzyme gene polymorphism and salt sensitivity in essential hypertension. , 1996, Hypertension.

[23]  H. Schunkert,et al.  Angiotensin-converting enzyme in the human heart. Effect of the deletion/insertion polymorphism. , 1995, Circulation.

[24]  P Whelton,et al.  Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population. Data from the health examination surveys, 1960 to 1991. , 1995, Hypertension.

[25]  R Kreutz,et al.  A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease. , 1995, The New England journal of medicine.

[26]  P Whelton,et al.  Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991. , 1995, Hypertension.

[27]  B. Brenner,et al.  Hypertension: Pathophysiology, Diagnosis, and Management , 1994 .

[28]  T. Inenaga,et al.  The association between salt sensitivity of blood pressure and some polymorphic factors , 1994, Journal of hypertension.

[29]  Lippincott Williams Wilkins,et al.  1993 guidelines for the management of mild hypertension. Memorandum from a World Health Organization/International Society of Hypertension meeting. Guidelines Subcommittee of the WHO/ISH Mild Hypertension Liaison Committee. , 1993, Hypertension.

[30]  O. Costerousse,et al.  Angiotensin I-converting enzyme in human circulating mononuclear cells: genetic polymorphism of expression in T-lymphocytes. , 1993, The Biochemical journal.

[31]  L. Tiret,et al.  Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. , 1992, American journal of human genetics.

[32]  J. Laragh,et al.  Diagnosis Ex Juvantibus Individual Response Patterns to Drugs Reveal Hypertension Mechanisms and Simplify Treatment , 1988, Hypertension.

[33]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[34]  A. Guyton,et al.  Renin, Aldosterone, Body Fluid Volumes, and the Baroreceptor Reflex in the Development and Reversal of Goldblatt Hypertension in Conscious Dogs , 1974, Circulation research.

[35]  J. Laragh.  Vasoconstriction-volume analysis for understanding and treating hypertension: the use of renin and aldosterone profiles. , 1973, The American journal of medicine.

[36]  Ş..  Plasma renin in long-term diuretic treatment of hypertension : effect of discontinuation and restarting therapy , 2022 .